DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Department of Defense
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials. Applications must address one of the following focus areas: · Biomarker-Driven Interventions: Disease-modifying interventions, with mechanism-specific biomarkers to predict which clinical trial participants are likely to respond, demonstrate target engagement, and effects on the intended biological pathway. · Clinical Car
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
05/04/2026
Closes
2026-09-30
Eligibility
Eligibility
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Program
Funding area
Science and Technology and other Research and Development - ST
Opportunity #
HT942526ALSRPPCTA
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov